China NMPA Inspection - Jiangsu Xidi Pharmaceuticals Co., Ltd - August 18, 2020
China NMPA unannounced inspection for Jiangsu Xidi Pharmaceuticals Co., Ltd published August 18, 2020. The National Medical Products Administration (NMPA) of China issued a notification on August 18, 2020, announcing an unannounced inspection of Jiangsu
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA unannounced inspection for Jiangsu Xidi Pharmaceuticals Co., Ltd published August 18, 2020. The National Medical Products Administration (NMPA) of China issued a notification on August 18, 2020, announcing an unannounced inspection of Jiangsu
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
Unknown Date
Product Type
drugs
ID: 56299a7f-5d67-4d19-9b3e-4a848bac52df
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox